Quantum Genomics S.A. (QNNTF)
QNNTF Stock Price Chart
Explore Quantum Genomics S.A. interactive price chart. Choose custom timeframes to analyze QNNTF price movements and trends.
QNNTF Company Profile
Discover essential business fundamentals and corporate details for Quantum Genomics S.A. (QNNTF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
19 May 2021
Employees
3.00
Website
https://www.quantum-genomics.comCEO
Mathieu Bigois
Description
Quantum Genomics Société Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It develops drugs based on brain aminopeptidase A inhibition (BAPAI) platform primarily to treat high blood pressure and heart failure. The company develops firibastat, a monotherapy drug that is in pivotal Phase III study for the treatment of hypertension, as well as in clinical trial for the treatment of heart failure. It is also developing QGC011 to treat hypertension with combination therapy; and QGC006 and QGC606 drug for the treatment of hypertension and heart failure. The company was incorporated in 2005 and is based in Paris, France.
QNNTF Financial Timeline
Browse a chronological timeline of Quantum Genomics S.A. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Apr 2026
Upcoming earnings on 28 Apr 2026
Upcoming earnings on 27 Oct 2025
Upcoming earnings on 27 Oct 2025
Earnings released on 30 Apr 2025
Earnings released on 28 Mar 2025
Earnings released on 29 Oct 2024
Earnings released on 29 Jun 2024
EPS came in at -$0.25 , while revenue for the quarter reached $2.21K .
Earnings released on 24 Apr 2024
Earnings released on 13 Mar 2024
EPS came in at -$0.04 , while revenue for the quarter reached $13.20 .
Earnings released on 5 Oct 2023
Earnings released on 30 Jun 2023
EPS came in at -$0.06 , while revenue for the quarter reached $10.97K .
Earnings released on 31 Dec 2022
EPS came in at -$0.43 falling short of the estimated -$0.19 by -125.74%, while revenue for the quarter reached $141.11 , missing expectations by -100.00%.
Earnings released on 5 Oct 2022
EPS came in at -$0.42 , while revenue for the quarter reached $938.28K .
Earnings released on 2 May 2022
EPS came in at -$0.47 falling short of the estimated -$0.26 by -80.04%, while revenue for the quarter reached $3.89M .
Earnings released on 6 Oct 2021
EPS came in at -$0.27 falling short of the estimated -$0.19 by -43.56%, while revenue for the quarter reached $3.21M , missing expectations by -54.90%.
Earnings released on 18 Aug 2021
Earnings released on 30 Jun 2021
EPS came in at -$0.27 , while revenue for the quarter reached $120.59K .
Earnings released on 25 Mar 2021
EPS came in at -$0.67 falling short of the estimated $0.08 by -932.26%, while revenue for the quarter reached $4.86M .
Earnings released on 1 Oct 2020
EPS came in at -$0.25 surpassing the estimated -$0.31 by +19.35%, while revenue for the quarter reached $16.66K .
QNNTF Stock Performance
Access detailed QNNTF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.